Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Innovation in HIV Vaccine and HIV Cure Research

McMaster University

$100,000.00

A humanized mouse model for understanding HIV-1 mucosal pathogenesis

FY 2012-13

Summary
More than 70% of HIV infection occurs via heterosexual or homosexual transmission. Women account for roughly 50% of HIV infected people globally and in women HIV transmission occurs primarily through heterosexual intercourse. In order to infect women, HIV needs to cross the mucosal lining of their genital tract before it can establish infection in target immune cells. The mucosal lining of the female genital tract is made up of epithelial cells. These cells are exquisitely sensitive and respond distinctly to various stimuli in their environment. In our previous studies we found that when female genital tract epithelial cells were grown in culture and exposed to HIV, they made inflammatory immune factors that resulted in breaking of the mucosal barrier. This allowed HIV to exploit the responses of the epithelial lining such that both the virus and other bacteria could now cross the mucosal barrier. These studies suggested that this mechanism may explain why HIV infection causes chronic inflammation seen in HIV-infected people. This chronic inflammation (known as immune activation) is known to correlate with progression to AIDS and adverse outcomes for HIV-infected persons. In this application we propose to apply the knowledge we have acquired from the cell culture system to a physiologically more relevant and complex mouse model where the immune system of the mouse has been replaced by human immune cells (humanized mouse). Using this model we will examine whether infection with HIV in the genital tract indeed causes the breaking of mucosal barrier and results in immune activation. If so, we plan to apply novel formulations that will protect the mucosal barrier and then examine if HIV is unable to cause infection and/or immune activation. These studies will increase our understanding of how HIV causes infection in the female genital tract and then devise methods to stop the infection.
Program
Catalyst Grant: Innovation in HIV Vaccine and HIV Cure Research
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
276908
Name
Kaushic Charu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
HIV Vaccine and Cure Research
Projecttitle
A humanized mouse model for understanding HIV-1 mucosal pathogenesis
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Innovation in HIV Vaccine and HIV Cure Research
Keyworddelim
Barrier Function; Disease Model; Hiv-1; Humanized Mouse; Immune Activation; Inflammation; Mucosal Immunity; Pathogenesis; Prophylaxis
Abstract
More than 70% of HIV infection occurs via heterosexual or homosexual transmission. Women account for roughly 50% of HIV infected people globally and in women HIV transmission occurs primarily through heterosexual intercourse. In order to infect women, HIV needs to cross the mucosal lining of their genital tract before it can establish infection in target immune cells. The mucosal lining of the female genital tract is made up of epithelial cells. These cells are exquisitely sensitive and respond distinctly to various stimuli in their environment. In our previous studies we found that when female genital tract epithelial cells were grown in culture and exposed to HIV, they made inflammatory immune factors that resulted in breaking of the mucosal barrier. This allowed HIV to exploit the responses of the epithelial lining such that both the virus and other bacteria could now cross the mucosal barrier. These studies suggested that this mechanism may explain why HIV infection causes chronic inflammation seen in HIV-infected people. This chronic inflammation (known as immune activation) is known to correlate with progression to AIDS and adverse outcomes for HIV-infected persons. In this application we propose to apply the knowledge we have acquired from the cell culture system to a physiologically more relevant and complex mouse model where the immune system of the mouse has been replaced by human immune cells (humanized mouse). Using this model we will examine whether infection with HIV in the genital tract indeed causes the breaking of mucosal barrier and results in immune activation. If so, we plan to apply novel formulations that will protect the mucosal barrier and then examine if HIV is unable to cause infection and/or immune activation. These studies will increase our understanding of how HIV causes infection in the female genital tract and then devise methods to stop the infection.
Competitiondate
201211
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kaushic, Charu
Approvedterm
1 an 0 mois
Cihrcontribution2
HIV/AIDS~ $100,000~ $0~